CompletedPhase 2NCT00200538

Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients

Studying Frontotemporal dementia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Nantes University Hospital
Principal Investigator
Martine Vercelletto, MD, M.D
Centre de la Mémoire, Clinique Neurologique CHU Nord Nantes 44093 France; mvercelletto@chu-nantes.fr
Intervention
memantine(drug)
Enrollment
52 enrolled
Eligibility
45-75 years · All sexes
Timeline
2005

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00200538 on ClinicalTrials.gov

Other trials for Frontotemporal dementia

Additional recruiting or active studies for the same condition.

See all trials for Frontotemporal dementia

← Back to all trials